Myocardial Infarction Research

Myocardial infarction (MI) - more commonly referred to as a heart attack - is an acute event caused by the interruption of blood supply to regions of the heart, leading to myocardial necrosis. Infarction of a substantial area of the myocardium can disrupt normal conductance of the heart, leading to cardiac arrest.In the majority of cases, an MI is immediately preceded by the presence of an occlusive thrombus within a coronary artery, blocking blood flow to the downstream tissue. The most common cause of an occlusive thrombus within a coronary artery is the rupture of an atherosclerotic plaque. However, the occlusion of a coronary artery may also result from coronary embolism. This can occur in patients following stent placement, angioplasty, and coronary artery bypass grafting.

Myocardial Infarction Research Products Targets

Products for Myocardial Infarction Research - Page 6

  1. Cat.No. Product Name Information/Activity
  2. BCC6998 GR 144053 trihydrochloride 1215333-48-4 GR 144053 trihydrochloride chemical structure
  3. BCC5938 KF 38789 257292-29-8 KF 38789 chemical structure
  4. BCC6229 LDV FITC 1207610-07-8 LDV FITC chemical structure
  5. BCC6332 Leukadherin 1 Leukadherin-1 is a specific agonist of complement receptor 3 (CR3) and the leukocyte surface αMβ2 integrin CD11b/CD18. Leukadherin 1 chemical structure
  6. BCC3943 MNS MNS is a potent and selective inhibitor of Src and Syk tyrosine kinases. MNS chemical structure
  7. BCC7458 OGT 2115 OGT 2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT 2115 has anti-angiogenic properties (IC50 of 1 μM). OGT 2115 also inhibits heparan sulfate degradation activity. OGT 2115 chemical structure
  8. BCC6275 P11 848644-86-0 P11 chemical structure
  9. BCC6105 PM 102 1234564-95-4 PM 102 chemical structure
  10. BCC7694 RGDS peptide Arg-Gly-Asp-Ser is an integrin binding sequence that inhibits integrin receptor function, decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, iNOS and MMP-9. RGDS peptide chemical structure
  11. BCC7894 RWJ 50271 RWJ 50271 is an selective inhibitor of lymphocyte function-associated antigen-1/intercellular adhesion molecule-1(LFA-1/ICAM-1) interaction with an IC50 of 5.0 μM (HL60 cells). RWJ 50271 chemical structure

Items 51 to 60 of 400 total